期刊文献+

糖尿病肾病患者血清CC趋化因子升高并与AGE-肽相关 被引量:4

Elevated CC chemokines correlate with AGE-peptide in the serum of patients with diabetic nephropathy
下载PDF
导出
摘要 目的:观察糖尿病肾病(DN)患者血清单核细胞趋化蛋白-1(MCP-1)和受活化调节、由正常T细胞表达分泌的趋化蛋白(RANTES)水平,并探讨它们与糖基化终产物-肽(AGE-P)的相互关系。方法:设健康对照(NC)组46例,糖尿病(DM)患者176例分为正常蛋白尿(DM N)组、微量白蛋白尿(DM Mi)组及显性蛋白尿(DM Ma)组。流动注射分析法检测血清AGE-P,ELISA法检测血清MCP-1和RANTES。结果:(1)DM患者血清MCP-1、RANTES和AGE-P水平均明显高于NC组(均为P<0.01);(2)DM Ma组和DM Mi组血清MCP-1水平均显著高于DM N组(均为P<0.05);(3)DM Ma组血清AGE-P水平明显高于DM Mi组和DM N组(P<0.05和P<0.01);(4)DN患者血清AGE-P与RANTES及MCP-1水平之间呈正相关(r=0.31,P<0.05;r=0.53,P<0.001)。结论:DM患者血清AGE-P、RANTES和MCP-1水平升高;血清AGE-P及MCP-1水平与DN病变程度平行,DN患者血清AGE-P与RANTES及MCP-1呈正相关。 Objective To investigate the serum level of MCP-1 and RANTES in patients with diabetic nephropathy (DN) and explore the relationship between advanced glycosylation end products-peptide (AGE-P) and these two chemokines. Methods 46 healthy people and 176 diabetic patients (DM) were included in the study. Serum AGE-P was measured by using flow injection assay. MCP-1 and RANTES was determined by using ELISA. Results The serum MCP-1, RANTES and AGE-P were significantly increased compared to normal control ( P 〈 0.01 ). The serum MCP-1 instead of RANTES in patients with overt proteinufia and micro-albuminuria were significant higher than that in DM patients without albuminuria ( P 〈 0.05). Serum AGE-P in patients with overt proteinufia was significant higher than that in DM patients with micro-albuminuria ( P 〈 0.05) or without albuminuria (P 〈 0.01). Serum AGE-P showed significantly positive correlation with MCP-1 (r = 0.53, P 〈 0.001 ) and RANTES ( r = 0.31, P 〈 0.05) in DN patients. Conclusions Serum AGE-P, MCP- 1 and RANTES are increased in DM patients. Serum AGE-P correlates to MCP-1 and RANTES. These data suggest that the interaction of AGEs with CC chemokines may contribute to the development of DN.
出处 《东南大学学报(医学版)》 CAS 2005年第6期385-389,共5页 Journal of Southeast University(Medical Science Edition)
基金 东南大学科技基金资助项目(XJ002666)
关键词 趋化因子 单核细胞趋化蛋白-1 受活化调节 由正常T细胞表达分泌的趋化蛋白 糖基化终产物-肽 糖尿病肾病 chemokine monocyte chemoattractant protein-l regulated upon activation, normal T cell expressed and secreted advanced glycosylation end products-peptide diabetic nephropathy
  • 相关文献

参考文献15

二级参考文献38

  • 1Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycosylation end productinduced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem, 2002,277:20309-20315.
  • 2Banba NY, Nakamura T, Matsumuka M,et al. Possible relationship of monocyte chemoattractant protein- 1 with diabetic nephropathy. Kidney Int, 2000, 58: 684-690.
  • 3WANG S N, laPAGE J, HIRSCHBERG R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy[J]. Kidney Int, 2000, 57: 1002-1014.
  • 4SINGH R, BARDEN A, MORI T, et al. Advanced glycation end products: a review[J]. Diabetologia, 2001,44 : 129-146.
  • 5ROVIN B H, SCHREINER G F. Cell-mediated immunity in glomerular disease[J]. Annu Rev Med, 1991,42.25-33.
  • 6YOUNG B A, JOHNSON R J, ALPERS C E, et al. Cellular events in the evolution of experimental diabetic nephropathy[J]. Kidney Int, 1995,47:935-944.
  • 7BACON K B, PREMACK B A, GARDNER P, et al. Activation of dual T cell signaling pathways by the chemokine RANTES[ J ]. Science, 1995,269 : 1727-1730.
  • 8KUNA P,REDDIGARI S R,SCHALL T J ,et al. RANTES,a monocyte and T lymphocyte chemoatactic cytokine releases histarnine from human basophils[ J ]. J Immunol, 1992,149 : 636-642.
  • 9SCHALL T J, BACON K, TOY K J, et al. Selective attraction of monocyte and T lymphocytes of memory phenotype by cytokine RANTES[ J ]. Nature, 1990,347 : 669-671.
  • 10NATORI Y, SEKIGUCHI M, NATORI Y. Expression of mRNA of C-C chernokines in experimental crescentic glomerulonephritis[ J ]. J Am Soc Nephrol, 1995,6: 845.

共引文献44

同被引文献49

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部